SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002731
Filing Date
2022-03-03
Accepted
2022-03-03 07:35:54
Documents
12
Period of Report
2022-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20220302.htm   iXBRL 8-K 72310
  Complete submission text file 0000950170-22-002731.txt   191620

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220302.xsd EX-101.SCH 2494
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220302_pre.xml EX-101.PRE 11037
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220302_lab.xml EX-101.LAB 13438
6 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220302_htm.xml XML 4699
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 22706755
SIC: 2834 Pharmaceutical Preparations